Other Species / Isoforms
  FGF23 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
Y51-p
TATARNSyHLQIHKN
0 1
FGF23 (human) TATARNSyHLQIHKN Y51-p
FGF23 (mouse) TATARTSYHLQIHRD Y51
Y70-p
GAPHQTIysALMIRS
0 1
FGF23 (human) GAPHQTIysALMIRS Y70-p
FGF23 (mouse) GTPHQTIYSALMITS Y70
S71-p
APHQTIysALMIRSE
0 1
FGF23 (human) APHQTIysALMIRSE S71-p
FGF23 (mouse) TPHQTIYSALMITSE S71
Y154-p
PGMNPPPysQFLsRR
0 1
FGF23 (human) PGMNPPPysQFLsRR Y154-p
FGF23 (mouse) PGTNPPPFSQFLARR F154
S155-p
GMNPPPysQFLsRRN
0 1
FGF23 (human) GMNPPPysQFLsRRN S155-p
FGF23 (mouse) GTNPPPFSQFLARRN S155
S159-p
PPysQFLsRRNEIPL
0 1
FGF23 (human) PPysQFLsRRNEIPL S159-p
FGF23 (mouse) PPFSQFLARRNEVPL A159
T178-ga
TPIPRRHtRsAEDDS
1 1
FGF23 (human) TPIPRRHtRsAEDDS T178-ga
FGF23 (mouse) TVRPRRHTRSAEDPP T178
S180-p
IPRRHtRsAEDDSER
Upstream
Downstream
2 2
Effects on Modified Protein
  • O-GalNAc glycosylation
  • protein degradation
Kinase, in vitro:
  • FAM20C (human)
Putative in vivo kinases:
  • FAM20C (human)
  • FAM20C (mouse)
FGF23 (human) IPRRHtRsAEDDSER S180-p
FGF23 (mouse) RPRRHTRSAEDPPER S180
S207-p
TPAPASCsQELPsAE
Upstream
1 1
Putative in vivo kinases:
  • FAM20C (mouse)
FGF23 (human) TPAPASCsQELPsAE S207-p
FGF23 (mouse) TPVPVSCSRELPsAE S207
S212-p
SCsQELPsAEDNSPM
Upstream
1 1
Putative in vivo kinases:
  • FAM20C (mouse)
FGF23 (human) SCsQELPsAEDNSPM S212-p
FGF23 (mouse) SCSRELPsAEEGGPA S212-p